Business Insider

Marengo Therapeutics Advances First-In-Class Selective T cell Activator, STAR0602, into Human Trials in Solid Tumors and Enters Cooperative Research and Development Agreement ...

CAMBRIDGE, Mass., Sept. 16, 2022 /PRNewswire/ -- Marengo Therapeutics, a company pioneering novel therapeutics targeting the T cell receptor Vβ chain (TCR Vβ) to selectively activate the right T cell ...
Business Insider

Marengo Therapeutics Presents Preclinical Proof-of Concept Data for STAR0602, a First-in-class Selective T cell Activator, at the 34th EORTC-NCI-AACR Symposium 2022

CAMBRIDGE, Mass., Oct. 28, 2022 /PRNewswire/ -- Marengo Therapeutics, Inc., a company pioneering novel therapeutics targeting the T cell receptor Vβ chain (TCR Vβ) to selectively activate the right T ...
JSTOR Daily

Interleukin-6 is an activator of pituitary stem cells upon local damage, a competence quenched in the aging gland

Stem cells in the adult pituitary are quiescent yet show acute activation upon tissue injury. The molecular mechanisms underlying this reaction are completely unknown. We applied single-cell ...
Business Wire

Nanotein engages Akron Bio for the cGMP production of its NanoSpark™ STEM-T Soluble T Cell Activator

BERKELEY, Calif.--(BUSINESS WIRE)--Nanotein Technologies, Inc. (“Nanotein”), a technology development company with next-generation immune cell activation reagents leveraging its proprietary NanoSpark® ...
Morningstar

BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health

Xcellara™ Stem Cell Activator has been scientifically shown to significantly increase circulating stem cells in humans, dogs, horses, and other mammals. Stem cells foster cellular regeneration and ...
BioWorld

NKT activator shows promise in mouse models of lupus nephritis

Gri Bio Inc. reported data on its type 2 natural killer T (NKT) cell activator GRI-0803 at the Autoimmunity Conference hosted by FASEB earlier in August. The company is developing GRI-0803 in ...